Displaying 1 - 1 of 1
| Active Ingredient | PREGABALIN |
| Therapeutic Class | ANTICONVULSANTS MISCELLANEOUS |
| Indications | Peripheral and central neuropathic pain, adjunctive therapy for focal seizures with or without secondary generalization. |
| Caution | Dry mouth, constipation, vomiting, flatulence, oedema, dizziness, drowsiness, irritability, impaired attention, disturbances in muscle control and movement, speech disorder, impaired memory . |
| Dose Range |
Adult: Neuropathic pain: Initially 150 mg daily in 2-3 divided doses. Maximum dose 600mg daily in divided doses. Epilepsy: 150 mg daily increased after 1 week according to response 300 mg daily in 2-3 divided doses. Maximum dose 600mg daily in divided dos |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |